Mortality (all‐cause) · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (all‐cause) compared with any control treatment (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (cardiovascular) compared with any control treatment (moderate certainty).
1 finding from 1 review
Myocardial infarction · any patient population and people with high cardiovascular risk
Colchicine probably leads to lower myocardial Infarction (total) compared with any control treatment (moderate certainty).
1 finding from 1 review
Adverse event (total) · any patient population and people with high cardiovascular risk
It is very uncertain whether colchicine changes adverse event (total) compared with any control treatment (very low certainty).
1 finding from 1 review
Gastrointestinal adverse events · any patient population and people with high cardiovascular risk
Colchicine may leads to higher adverse event (gastrointestinal) compared with any control treatment (low certainty).
1 finding from 1 review
Adverse event (serious) · any patient population and people with high cardiovascular risk
1 finding from 1 review
Heart failure · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in heart failure (total) compared with any control treatment (low certainty).
1 finding from 1 review
Stroke · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in stroke (total) compared with any control treatment (low certainty).
1 finding from 1 review